Q3: Can I stop GLP-1s once I reach my goal
According to the FDA and KDIGO-ADA 2022 guidelines, liraglutide, semaglutide, and tirzepatide generally do not require dose adjustments in CKD patients
Going forward, special attention should be paid to the exploration of potential unwanted effects, particularly those affecting cardiovascular health with heart rate being one of the easiest variables to monitor
Hormones, menopause, and brain resilience Hormones are not the whole dementia story, but they are part of the physiologic landscape
Insulin resistance causes excess sugar to be stored as fat, and poor lymphatic circulation results in toxin and fluid retention, exacerbating bloating and fat accumulation
Over the next five years, the marketplace will only grow more crowded: cheaper generics, oral pills replacing injections, and an escalating marketing war as companies expand indications from diabetes and obesity into sleep apnea, fatty liver disease, even addiction